Diagnostic accuracy of a pH stick, modified to detect gastric lipase, to confirm the correct placement of nasogastric tubes by Rowat, Anne M et al.
1Rowat AM, et al. BMJ Open Gastro 2018;5:e000218. doi:10.1136/bmjgast-2018-000218
Diagnostic accuracy of a pH stick, 
modified to detect gastric lipase, 
to confirm the correct placement of 
nasogastric tubes
Anne M Rowat,1 Catriona Graham,2 Martin Dennis3
To cite: Rowat AM, Graham C, 
Dennis M. Diagnostic 
accuracy of a pH stick, 
modified to detect gastric 
lipase, to confirm the correct 
placement of nasogastric 
tubes. BMJ Open Gastro 
2018;5:e000218. doi:10.1136/
bmjgast-2018-000218
Received 31 May 2018
Revised 29 June 2018
Accepted 5 July 2018
1School of Health and Social 
Care, Edinburgh Napier 
University, Edinburgh, UK
2Edinburgh Clinical Research 
Facility, University of Edinburgh, 
Western General Hospital, 
Edinburgh, UK
3Centre for Clinical Brain 
Sciences, University of 
Edinburgh, Edinburgh, UK
Correspondence to
Dr Anne M Rowat;  
 a. rowat@ napier. ac. uk
Endoscopy
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published 
by BMJ.
AbsTrACT
Objective The correct placement of a nasogastric feeding 
tube is usually confirmed by establishing that an aspirate 
is acidic using a pH stick. However, antacid medication 
and achlorhydria can cause false negative pH tests that 
may delay feeding and increase resource use. The purpose 
of this study was to evaluate a modified pH stick designed 
to detect gastric lipase and therefore reduce false negative 
tests.
Methods In this prospective observational study, a 
convenience sample of adult patients who had either 
gastric and oesophageal samples taken during routine 
diagnostic gastroscopy (n=97) or bronchial and saliva 
samples taken during a bronchoscopy (n=106). The 
samples were tested by blinded observers using the 
modified and standard pH sticks. The sensitivities and 
specificities of the two pH sticks in identifying gastric and 
non-gastric aspirates were compared using the pH cut-off 
≤5.5.
results The sensitivities of a pH≤5.5 to correctly identify 
gastric samples were 66% (95% CI 56 to 75) and 68% 
(95% CI 57 to 77) for the modified and the standard pH, 
respectively. The specificities were 81% (95% CI 76 to 
85) and 79% (95% CI 74 to 84). There were no significant 
differences in the distribution of the discordant results 
between the paired gastric and non-gastric samples for 
both the modified and standard pH sticks at pH≤5.5 (both 
McNemar’s tests, p≥0.05).
Conclusions There were no significant differences 
between the paired modified and standard pH tests for 
the gastric samples. Due to the limited accuracy of pH 
sticks, further research is required to identify accurate 
and cost-effective bedside methods to confirm the correct 
placement of nasogastric tubes.
IntroductIon
The pH of an aspirate cut-off ≤5.5 is commonly 
used as the first-line test to confirm that the 
nasogastric tube (NGT) is correctly posi-
tioned in the stomach.1 However, it has been 
reported that false negative pH tests (>5.5) 
can occur in patients who secrete less gastric 
acid, because they receive antacid medica-
tions, achlorhydria or buffering by NGT 
feeds.2–4 This can lead to significant delays 
to feeding and greater use of chest X-rays to 
visually confirm the NGT position.5 However, 
misinterpretation of X-rays can lead to signif-
icant feeding errors.6 
A proposed solution to check non-acid 
gastric aspirates is by using stomach specific 
enzyme-based diagnostic tests for NGT 
confirmation. Human gastric lipase (HGL) is 
mostly secreted from the gastric fundus and is 
considered to be one of the most acid stable 
stomach enzymes.7 HGL is able to hydrolyse 
dietary triglycerides that results in the release 
of butyric acid and alcohol.8 Therefore, the 
summary box
What is already known about this subject?
 ► Current guidelines recommend that the first-line 
test to confirm nasogastric tube (NGT) position is 
that the pH of a gastric aspirate is ≤5.5.
 ► Patients on antacid medications more often have 
false negative pH tests (>5.5), which delays feed-
ing and increases the number of chest X-rays (sec-
ond-line test) to confirm NGT position.
 ► A previous study found that modified pH sticks, 
coated with triglyceride to detect human gastric li-
pase (HGL), were more sensitive to correctly identify 
NGT position than standard pH sticks.
What are the new findings?
 ► There were no significant differences between the 
paired modified and standard pH tests to differen-
tiate gastric from non-gastric samples taken from 
fasting patients at pH≤5.5.
 ► The accuracy of pH remained unchanged, regard-
less of whether patients were taking antacid med-
ication or not.
How might it impact on clinical practice in the 
foreseeable future?
 ► Further refinement of the modified pH stick to accu-
rately detect NGT placement is required, including 
investigation of the stability of tributyrin coated on 
different types and makes of sticks and of HGL ac-
tivity in different patient populations.
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presence of lipase might be measured through detecting 
the acid derived from the breakdown of triglycerides.9 
However, the HGL activity is only stable between pH 
3.0 and 7.0 and is inactive at very acidic (pH≤2.0) and 
alkaline pH values (pH>8.0).7 9 10 Therefore, a combined 
test that measures both pH and HGL activity has been 
hypothesised to be more accurate than the pH test in 
isolation.9 Modified pH sticks that detect HGL (pH stick 
supplied by Merck, New Jersey, USA, Ref: 1095840001), 
which is coated with tributyrin (Ingenza, Roslin, Scot-
land), were also found to be more sensitive to correctly 
identify NGT placement than standard pH sticks (97% 
(95% CI 85 to 100) vs 66% (95% CI 48 to 81)).9 However, 
the sample size was small, including only 36 patients who 
had aspirates taken from NGTs.
The aim of this study was to compare the diagnostic 
accuracy of pH measurements using modified HGL and 
standard pH stick results on aspirates obtained during 
gastroscopy or bronchoscopy at the recommended pH 
cut-off of ≤5.5.
Methods
This study was carried out as part of a broader study of 
the accuracy of pH testing to distinguish gastric aspirate 
from aspirates from other sites, which has been previ-
ously published.11
Participants
In this prospective observational study, a convenience 
sample of adults (≥16 years) who were referred for a first 
elective diagnostic gastroscopy or bronchoscopy in two 
UK teaching hospitals between 1 November 2014 and 
20 December 2016 were eligible for the study. Eligible 
patients had data regarding the use of antacid medica-
tion or conditions/surgery that might affect the pH of 
any aspirate results. Patients were excluded if they were 
having follow-up procedures, if they lacked mental 
capacity or the specimens were considered high risk, 
including known tuberculosis, blood or airborne viruses.
data collection
Two aspirates were taken per patient during either 
gastroscopy (gastric and oesophageal samples) or bron-
choscopy (bronchial and saliva samples). Each oper-
ator followed site-specific guidance for the collection 
of gastric, oesophageal and bronchial samples. Patients 
undergoing bronchoscopy were also asked to spit salvia 
into labelled containers prior to the procedure. Between 
5 and 10 mL of each type of aspirate were placed into 
universal containers, which were immediately put on ice 
to preserve any HGL activity in the gastric fluid for up 
to 2 hours.10 The reference standard was direct confirma-
tion of the type of aspirate confirmed by the operator 
undertaking the procedure.
The standard CE-marked pH stick was supplied by 
Enteral UK, North Duffield, UK. A biochemist coated 
the same pH test paper with tributyrin (Ingenza, Roslin, 
Scotland, patent W02011068891A1). It was hypothesised 
that both sticks would be able to detect hydrochloric acid 
if present in the stomach (pH≤5.5). However, if there 
was no hydrochloric acid but HGL was present in the 
stomach, the HGL would break down the tributyrin on 
the modified stick to produce butyric acid providing an 
acidic response.9 Both the standard and modified pH 
sticks were stored at room temperature in a cool dry 
place away for direct sunlight, as per the pH stick manu-
facturers’ instructions, with a minimum expiration date 
of 3 years. The pH stick scale ranges from 2.0 to 9.0 with 
three colour blocks in intervals of 0.5 pH units.
The research nurses tested one of each of the samples 
with the two visually identical pH sticks, one standard and 
one modified to test HGL, within 2 hours of the sample 
being collected from the patient. The research nurses 
were blind to the type of stick used and each of the pH 
sticks were given a code, so they could not be identified 
when testing the specimens. The research nurses followed 
a standard operating procedure to ensure that each spec-
imen was pipetted from the container to cover the two 
different types of pH stick (modified and standard) sepa-
rately to prevent cross-contamination of samples. The 
colour of the sticks was compared after 60 s with that on 
the container. Although visual colour impairment was 
not formally tested, the research nurses all indicated they 
had normal colour vision.
Patient involvement
No patients were involved in the design or implementa-
tion of this study.
Analyses
Demographic categorical data are presented as percent-
ages, the median (IQR), frequencies and 95% CI. In 
order to identify the sensitivity, specificity, positive/
negative predictive values (PV) and the positive/nega-
tive likelihood ratios (LR) for the standard and modified 
pH tests, the cut-off values were aligned to the clinically 
agreed standards for testing pH, that is, ≤5.5 was classified 
as acidic sample whereas >5.5 was classified as non-acidic 
sample. All data analyses were performed using Statistical 
Analysis System Institute, SAS V.9.4, Cary, North Caro-
lina, USA.
The sample size of 100 for each sample was estimated 
based on the 95% CIs and the majority of gastric aspirates 
having a pH≤5.5. However, the sample size could vary 
depending on how many patients have gastric secretions 
with a pH>5.5, as this was unknown we arbitrarily chose 
4% where pH might misclassify the samples. We expected 
no false positives samples when testing saliva or bronchial 
aspirate, which would give specificity of 100% (95% CI 
97 to 100). Therefore, we estimated that 200 patients 
each having two different samples each tested with the 
two types of pH sticks, taken during either gastroscopy 
(gastric and oesophageal samples) or bronchoscopy 
(bronchial and saliva samples) procedures would be 
required, providing a total of 800 (400 modified and 400 
standard) pH tests.
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results
A total of 203 patients were included, 97 (48%) had 
gastroscopy and 106 (52%) a bronchoscopy. Table 1 
shows 95 (47%) patients were male; 83 (41%) were 
taking antacid medication prior to the gastroscopy 
(42/97, 43%) or bronchoscopy (41/106, 39%); and 
3 (1%) had known pernicious anaemia, but these 
factors did not differ significantly between those who 
had a gastroscopy or bronchoscopy. Significantly more 
patients who had bronchoscopy (8/106, 8%) had 
previous gastric surgery than those who had a gastros-
copy (1/97, 1%) (Fisher’s Exact test, p=0.04). There 
were 390 samples tested with the standard stick and 379 
with the modified pH stick (figure 1).
The median standard and modified pH were similar 
for each of the different types of samples at pH≤5.5, both 
in the presence and absence of prior use of antacid medi-
cation and/or other confounding factors (table 2). The 
sensitivity of a pH≤5.5 to correctly identify gastric samples 
was 66% (95 CI 56 to 75) and 68% (95% CI 57 to 77) for 
the modified and standard pH sticks, respectively. The 
specificities were 81% (95 CI 76 to 85) and 79% (95% 
CI 74 to 84) for modified and standard pH sticks. There 
appeared to be no differences in the positive and negative 
PVs and LRs between the two types of pH stick (table 3).
The gastric pH was similar in those patients receiving 
antacid medications (median pH=2.0, IQR 2.0–6.6) 
compared with those who were not (median pH=2.3, IQR 
Table 1 The participant characteristics based on whether they had a gastroscopy (n=97) or bronchoscopy (n=106)
Gastroscopy Bronchoscopy Total
n % n % n %
Male 39 40 56 53 95 47
Female 58 60 50 47 108 53
Antacid medication 42 43 41 39 83 41
Proton pump inhibitor H2 39 40 40 38 79 39
Antagonist/combination 3 3 1 1 4 2
Previous gastric surgery 1 1 8 8 9 4
Pernicious anaemia 2 2 1 1 3 1
Total n of participants 97 100 106 100 203 100
Figure 1 STAndards for the Reporting of Diagnostic accuracy studies (STARD) diagram reporting the flow of participants 
through the study.
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2.0–6.5), regardless of the type of pH stick. In patients 
on antacids, the sensitivity of the pH of gastric samples 
(pH ≤5.5) was 67% (95 % CI 51 to 80) for the modified 
and 71% (95% CI 55 to 84) for the standard pH stick 
(table 3). The sensitivity of gastric samples remained 
similar when patients with pernicious anaemia (n=3) or 
had previous gastric surgery (n=9) were included in the 
analyses: modified stick=68% (95% CI 52 to 81) and stan-
dard stick=73% (95% CI 57 to 85).
Overall, there were no significant differences in the 
distribution of the discordant results between the paired 
gastric (McNemar’s test=0.50, p=0.5) and non-gastric 
(McNemar’s test=2.13, p=0.1) samples for both modified 
and standard sticks at pH≤5.5.
dIscussIon
In this study, the modified and standard pH sticks’ sensi-
tivity was low in terms of correctly identifying gastric aspi-
rate, regardless of whether patients were on antacids or 
had other confounding factors. It has been previously 
reported that standard pH testing can have sensitivity 
ranging between 66%-90% and the differences between 
results may depend on the type and make of pH indicator 
stick.3 9 11–13 It was surprising that the modified pH stick 
did not demonstrate higher sensitivities similar to those 
reported by the previous study, particularly in patients 
with a pH>5.5.9 We found that a third of the gastric 
samples had a pH>5.5 suggesting a high prevalence of 
Table 2 The proportion of samples from different sources with pH≤5.5 in the presence and absence of antacid medication
Sample pH stick
Median
(IQR)
All
Antacid 
medication
No
antacid
medication
All confounding 
factors*
Number with pH≤5.5/n (%)
Gastric Standard 2.5 (2.0–6.5) 65/96 (68) 30/42 (71) 35/54 (65) 32/44 (73)
Modified 2.5 (2.0–6.5) 62/94 (66) 28/42 (67) 34/52 (65) 30/44 (68)
Oesophageal Standard 5.0 (2.0–6.5) 59/90 (66) 26/41 (63) 33/49 (67) 26/42 (62)
Modified 5.5 (2.5–6.5) 53/89 (60) 22/40 (55) 31/49 (63) 22/41 (54)
Saliva Standard 7.0 (7.0–7.5) 2/101 (2) 2/40 (5) 0/61 (0) 2/43 (5)
Modified 7.0 (7.0–7.5) 2/97 (2) 1/37 (3) 1/60 (2) 1/41 (2)
Bronchial Standard 7.0 (6.5–7.5) 0/103 (0) 0/41 (0) 0/62 (0) 0/45 (0)
Modified 7.0 (7.0–7.5) 0/99 (0) 0/41 (0) 0/58 (0) 0/44 (0)
*Confounding factors included antacid medication, pernicious anaemia and/or gastric surgery.
Table 3 The diagnostic accuracy of the modified and standard pH stick tests for all gastric samples compared with non-
gastric samples tested at the pH≤5.5, including the absence or presence antacid medication
Diagnostic test
pH stick All
Antacid 
medication
No antacid
medication
All confounding 
factors*
Gastric pH≤5.5 versus all other samples (95% CI)
Sensitivity % Standard 68 (57 to 77) 71 (55 to 84) 65 (51 to 77) 73 (57 to 85)
Modified 66 (56 to 75) 67 (51 to 80) 65 (51 to 78) 68 (52 to 81)
Specificity % Standard 79 (74 to 84) 77 (69 to 84) 84 (74 to 86) 79 (70 to 85)
Modified 81 (76 to 85) 81 (72 to 87) 81 (70 to 87) 82 (74 to 88)
PPV % Standard 52 (45 to 58) 52 (42 to 61) 53 (44 to 62) 53 (44 to 62)
Modified 53 (46 to 59) 55 (44 to 65) 57 (46 to 67) 57 (46 to 67)
NPV % Standard 88 (85 to 91) 89 (83 to 93) 90 (84 to 93) 90 (84 to 93)
Modified 88 (84 to 90) 87 (81 to 91) 88 (83 to 92) 88 (83 to 92)
PLR Standard 3.3 (2.5 to 4.2) 3.1 (2.1 to 4.5) 4.0 (2.7 to 5.9) 3.4 (2.3 to 4.9)
Modified 3.4 (2.6 to 4.5) 3.4 (2.2 to 5.2) 3.4 (2.5 to 4.2) 4.0 (2.4 to 5.7)
NLR Standard 0.4 (0.3 to 0.5) 0.4 (0.2 to 0.6) 0.4 (0.3 to 0.6) 0.4 (0.2 to 0.6)
Modified 0.4 (0.3 to 0.6) 0.4 (0.3 to 0.6) 0.4 (0.3 to 0.6) 0.4 (0.3 to 0.6)
Overall
agreement %
Standard 76 (72 to 81) 76 (68 to 82) 77 (71 to 82) 77 (70 to 83)
Modified 77 (73 to 81) 77 (70 to 83) 77 (71 to 83) 78 (71 to 84)
*Confounding factors included antacid medication, pernicious anaemia and/or gastric surgery.
NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value.
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hypo/achlorhydria, which is likely to be more common 
in patients undergoing scope investigations.14 It was also 
predicted that patients taking antacid medication would 
have higher pH values than those not receiving antacid 
medications.2 However, in the current study, the accu-
racy of pH remained unchanged, regardless of whether 
patients were taking antacid medication or not. This may 
be a result of patients being required to fast for up to 
4 hours and/or having stopped their antacid medication 
prior to the procedure, which can increase gastric acid 
rebound hypersecretion.15 16
A strength of the current study was the large number 
of aspirates that were obtained from patients undergoing 
routine gastroscopy and bronchoscopy. NGT placement 
cannot be controlled and it would be unethical for 
patients to have unnecessary chest X-rays.17 Furthermore, 
aspirates cannot be obtained directly from NGTs in up to 
46% of patients.5 Although pH appears to be a cost effec-
tive first-line approach to confirm NGT,18 studies have 
shown that the accuracy of pH sticks remains mixed due 
to testers’ ability to obtain aspirate and visually differen-
tiate the colorimetric results.5 11 19 Previous studies have 
reported that misreading pH sticks can be influenced by 
a number of factors, including testers who have colour 
vision deficiency, time factors and poor lighting condi-
tions.5 19 However, there is a lack of evidence that the 
use of more expensive pH meters improves the accuracy 
to confirm correct NGT placement.3 Therefore, rede-
signing pH sticks to potentially reduce errors caused by 
visual inspection should be further investigated.5 11
It is unclear why this large study did not confirm the 
encouraging results of a similar smaller study.9 One 
explanation might be that different types of pH sticks 
were used, although both were prepared by the same 
laboratory. Studies comparing the different makes and 
types of pH stick have been found to either overestimate 
or underestimate pH in known buffer solutions.19 20 
Although pH sticks with multiple colour blocks used in 
this study are considered to be more accurate than single 
colour blocks when testing the pH of buffer solutions,20 
it was important to determine their performance with 
different aspirates taken from patients. Second, lipases 
may also originate from the tongue and the pharynx 
(lingual lipase); however, studies have found that 
gastric lipase is the predominant preduodenal enzyme 
in humans, with only trace amounts of lingual lipase 
activity detected from the small number of lingual serous 
glands compared with the larger stomach area.7 21 22 
These results were recently corroborated in a study that 
found no detectable lipase activity from saliva samples 
(unpublished data) and found that it was not present 
in lung aspirates.9 Third, in this study, the patients had 
been fasting prior to their procedure, which will reduce 
the production of gastrin that stimulates both HGL and 
hydrochloric acid secretion in the stomach.23 In the fed 
state, the conditions are more likely to be favourable 
for HGL, particularly at elevated pH levels between pH 
3.0 and 7.0.24 If this was indeed the case, HGL may be 
reduced or not present in the stomach and the modified 
pH stick would be unable to correct false negative results. 
Fourth, there may have been variability between methods 
used to obtain the samples during the procedure. It is 
not possible to confirm whether the gastroscopic proce-
dure could inadvertently result in alkaline duodenal fluid 
to be sampled or mixed the gastric secretions, particu-
larly when the patients are in the supine position.25 26 
However, there is conflicting evidence whether contam-
ination of gastric contents with bile salts, increases or 
decreases HGL activity.27 Finally, several conditions in 
humans, including pancreatitis, gastritis, cystic fibrosis 
and alcoholism, have significantly lower HGL activity 
when compared with healthy subjects.27 In this study, the 
specimens were deidentified as the aim was to compare 
the accuracy of both pH sticks on the different types of 
aspirate, therefore it was not possible to follow-up patients 
to confirm diagnosis postprocedure. Furthermore, the 
population undergoing scope procedures may not be 
generalisable to those requiring nasogastric feeding. 
Indeed, the NGT position requires to be checked prior 
to and after feeding and/or giving medications that will 
result in variable HGL activity.
Implications for practice and conclusion
Overall, the sensitivities of the modified and standard pH 
tests were low, but both were able to rule out all of the 
bronchial samples (100% specificity) at the pH cut-off 
≤5.5. The implications for practice based on the find-
ings from this study suggest further refinement of the 
modified pH stick is required, including investigation 
of the stability of HGL at very low and high pH values; 
the optimal shelf-life and storage of the tributyrin coated 
on different types and makes of pH sticks and the HGL 
activity in different patient populations, including fasting 
and feeding status and conditions that are associated 
with lipase insufficiency. Due to the limited accuracy 
of current colorimetric pH sticks, further research is 
urgently needed to determine more accurate methods 
that would reduce NGT misplacement and delays in 
feeding and would be safe, cost-effective, easy to use and 
improve patient outcomes.
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